{"id":12256,"date":"2023-02-13T04:17:49","date_gmt":"2023-02-12T20:17:49","guid":{"rendered":"https:\/\/www.pyrazoles-derivatives.com\/?p=12256"},"modified":"2023-02-13T04:17:49","modified_gmt":"2023-02-12T20:17:49","slug":"blake-james-f-et-al-published-their-research-in-journal-of-medicinal-chemistry-in-2016-cas-3528-58-3","status":"publish","type":"post","link":"https:\/\/www.pyrazoles-derivatives.com\/?p=12256","title":{"rendered":"Blake, James F. et al. published their research in Journal of Medicinal Chemistry in 2016 | CAS: 3528-58-3"},"content":{"rendered":"

Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1\/2 (ERK1\/2) Inhibitor in Early Clinical Development was written by Blake, James F.;Burkard, Michael;Chan, Jocelyn;Chen, Huifen;Chou, Kang-Jye;Diaz, Dolores;Dudley, Danette A.;Gaudino, John J.;Gould, Stephen E.;Grina, Jonas;Hunsaker, Thomas;Liu, Lichuan;Martinson, Matthew;Moreno, David;Mueller, Lars;Orr, Christine;Pacheco, Patricia;Qin, Ann;Rasor, Kevin;Ren, Li;Robarge, Kirk;Shahidi-Latham, Sheerin;Stults, Jeffrey;Sullivan, Francis;Wang, Weiru;Yin, Jianping;Zhou, Aihe;Belvin, Marcia;Merchant, Mark;Moffat, John;Schwarz, Jacob B.. And the article was included in Journal of Medicinal Chemistry in 2016.Electric Literature of C5H9N3<\/a> This article mentions the following:<\/p>\n

The extracellular signal-regulated kinases ERK1\/2 represent an essential node within the RAS\/RAF\/MEK\/ERK signaling cascade that is commonly activated by oncogenic mutations in BRAF or RAS or by upstream oncogenic signaling. While targeting upstream nodes with RAF and MEK inhibitors has proven effective clin., resistance frequently develops through reactivation of the pathway. Simultaneous targeting of multiple nodes in the pathway, such as MEK and ERK, offers the prospect of enhanced efficacy as well as reduced potential for acquired resistance. Described herein is the discovery and characterization of GDC-0994 (22), an orally bioavailable small mol. inhibitor selective for ERK kinase activity. In the experiment, the researchers used many compounds, for example, 1-Ethyl-1H-pyrazol-5-amine (cas: 3528-58-3Electric Literature of C5H9N3<\/a>).<\/p>\n

1-Ethyl-1H-pyrazol-5-amine (cas: 3528-58-3) belongs to pyrazole derivatives. Pyrazoles, a five-membered heterocycle containing two adjacent nitrogen atoms, are the core structures found in a number of molecules that possess a wide range of pharmaceutical and agricultural activities. Pyrazoles are commonly used scaffold molecules in drug discovery projects. The use of pyrazole derivatives is based on their analgesic, anti-inflammatory, antipyretic, antiarrhythmic, sedative, muscle relaxant, neuroleptic, anticonvulsant, monoamine oxidase inhibitory, antidiabetic and antibacterial activities.Electric Literature of C5H9N3<\/a><\/p>\n

Referemce:
Pyrazole – Wikipedia<\/a>,
Pyrazoles – an overview | ScienceDirect Topics<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

1-Ethyl-1H-pyrazol-5-amine (cas: 3528-58-3) belongs to pyrazole derivatives. Pyrazoles, a five-membered heterocycle containing two adjacent nitrogen atoms, are the core structures found in a number of molecules that possess a wide range of pharmaceutical and agricultural activities. Pyrazoles are commonly used scaffold molecules in drug discovery projects. The use of pyrazole derivatives is based on their analgesic, anti-inflammatory, antipyretic, antiarrhythmic, sedative, muscle relaxant, neuroleptic, anticonvulsant, monoamine oxidase inhibitory, antidiabetic and antibacterial activities.Electric Literature of C5H9N3<\/a><\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[830,131],"tags":[128],"class_list":["post-12256","post","type-post","status-publish","format-standard","hentry","category-3528-58-3","category-pyrazoles-derivatives","tag-100-200"],"yoast_head":"\nBlake, James F. et al. published their research in Journal of Medicinal Chemistry in 2016 | CAS: 3528-58-3 | pyrazoles-derivatives<\/title>\n<meta name=\"description\" content=\"Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1\/2 (ERK1\/2) Inhibitor in Early Clinical Development was written by Blake, James F.;Burkard, Michael;Chan, Jocelyn;Chen, Huifen;Chou, Kang-Jye;Diaz, Dolores;Dudley, Danette A.;Gaudino, John J.;Gould, Stephen E.;Grina, Jonas;Hunsaker, Thomas;Liu, Lichuan;Martinson, Matthew;Moreno, David;Mueller, Lars;Orr, Christine;Pacheco, Patricia;Qin, Ann;Rasor, Kevin;Ren, Li;Robarge, Kirk;Shahidi-Latham, Sheerin;Stults, Jeffrey;Sullivan, Francis;Wang, Weiru;Yin, Jianping;Zhou, Aihe;Belvin, Marcia;Merchant, Mark;Moffat, John;Schwarz, Jacob B.. And the article was included in Journal of Medicinal Chemistry in 2016.Electric Literature of C5H9N3 This article mentions the following:\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pyrazoles-derivatives.com\/?p=12256\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blake, James F. et al. published their research in Journal of Medicinal Chemistry in 2016 | CAS: 3528-58-3 | pyrazoles-derivatives\" \/>\n<meta property=\"og:description\" content=\"Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1\/2 (ERK1\/2) Inhibitor in Early Clinical Development was written by Blake, James F.;Burkard, Michael;Chan, Jocelyn;Chen, Huifen;Chou, Kang-Jye;Diaz, Dolores;Dudley, Danette A.;Gaudino, John J.;Gould, Stephen E.;Grina, Jonas;Hunsaker, Thomas;Liu, Lichuan;Martinson, Matthew;Moreno, David;Mueller, Lars;Orr, Christine;Pacheco, Patricia;Qin, Ann;Rasor, Kevin;Ren, Li;Robarge, Kirk;Shahidi-Latham, Sheerin;Stults, Jeffrey;Sullivan, Francis;Wang, Weiru;Yin, Jianping;Zhou, Aihe;Belvin, Marcia;Merchant, Mark;Moffat, John;Schwarz, Jacob B.. And the article was included in Journal of Medicinal Chemistry in 2016.Electric Literature of C5H9N3 This article mentions the following:\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pyrazoles-derivatives.com\/?p=12256\" \/>\n<meta property=\"og:site_name\" content=\"pyrazoles-derivatives\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-12T20:17:49+00:00\" \/>\n<meta name=\"author\" content=\"Jessica.F\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jessica.F\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=12256\",\"url\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=12256\",\"name\":\"Blake, James F. et al. published their research in Journal of Medicinal Chemistry in 2016 | CAS: 3528-58-3 | pyrazoles-derivatives\",\"isPartOf\":{\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#website\"},\"datePublished\":\"2023-02-12T20:17:49+00:00\",\"author\":{\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1\"},\"description\":\"Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1\/2 (ERK1\/2) Inhibitor in Early Clinical Development was written by Blake, James F.;Burkard, Michael;Chan, Jocelyn;Chen, Huifen;Chou, Kang-Jye;Diaz, Dolores;Dudley, Danette A.;Gaudino, John J.;Gould, Stephen E.;Grina, Jonas;Hunsaker, Thomas;Liu, Lichuan;Martinson, Matthew;Moreno, David;Mueller, Lars;Orr, Christine;Pacheco, Patricia;Qin, Ann;Rasor, Kevin;Ren, Li;Robarge, Kirk;Shahidi-Latham, Sheerin;Stults, Jeffrey;Sullivan, Francis;Wang, Weiru;Yin, Jianping;Zhou, Aihe;Belvin, Marcia;Merchant, Mark;Moffat, John;Schwarz, Jacob B.. And the article was included in Journal of Medicinal Chemistry in 2016.Electric Literature of C5H9N3 This article mentions the following:\",\"breadcrumb\":{\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=12256#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.pyrazoles-derivatives.com\/?p=12256\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=12256#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\/\/www.pyrazoles-derivatives.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blake, James F. et al. published their research in Journal of Medicinal Chemistry in 2016 | CAS: 3528-58-3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#website\",\"url\":\"https:\/\/www.pyrazoles-derivatives.com\/\",\"name\":\"pyrazoles-derivatives\",\"description\":\"Several pyrazole derivatives possess important pharmacological activities and they have been proved useful materials in drug research. Pyrazole derivatives play an important role in antitumor agents.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.pyrazoles-derivatives.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1\",\"name\":\"Jessica.F\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cn.cravatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/cn.cravatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g\",\"caption\":\"Jessica.F\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Blake, James F. et al. published their research in Journal of Medicinal Chemistry in 2016 | CAS: 3528-58-3 | pyrazoles-derivatives","description":"Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1\/2 (ERK1\/2) Inhibitor in Early Clinical Development was written by Blake, James F.;Burkard, Michael;Chan, Jocelyn;Chen, Huifen;Chou, Kang-Jye;Diaz, Dolores;Dudley, Danette A.;Gaudino, John J.;Gould, Stephen E.;Grina, Jonas;Hunsaker, Thomas;Liu, Lichuan;Martinson, Matthew;Moreno, David;Mueller, Lars;Orr, Christine;Pacheco, Patricia;Qin, Ann;Rasor, Kevin;Ren, Li;Robarge, Kirk;Shahidi-Latham, Sheerin;Stults, Jeffrey;Sullivan, Francis;Wang, Weiru;Yin, Jianping;Zhou, Aihe;Belvin, Marcia;Merchant, Mark;Moffat, John;Schwarz, Jacob B.. And the article was included in Journal of Medicinal Chemistry in 2016.Electric Literature of C5H9N3 This article mentions the following:","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pyrazoles-derivatives.com\/?p=12256","og_locale":"en_US","og_type":"article","og_title":"Blake, James F. et al. published their research in Journal of Medicinal Chemistry in 2016 | CAS: 3528-58-3 | pyrazoles-derivatives","og_description":"Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1\/2 (ERK1\/2) Inhibitor in Early Clinical Development was written by Blake, James F.;Burkard, Michael;Chan, Jocelyn;Chen, Huifen;Chou, Kang-Jye;Diaz, Dolores;Dudley, Danette A.;Gaudino, John J.;Gould, Stephen E.;Grina, Jonas;Hunsaker, Thomas;Liu, Lichuan;Martinson, Matthew;Moreno, David;Mueller, Lars;Orr, Christine;Pacheco, Patricia;Qin, Ann;Rasor, Kevin;Ren, Li;Robarge, Kirk;Shahidi-Latham, Sheerin;Stults, Jeffrey;Sullivan, Francis;Wang, Weiru;Yin, Jianping;Zhou, Aihe;Belvin, Marcia;Merchant, Mark;Moffat, John;Schwarz, Jacob B.. And the article was included in Journal of Medicinal Chemistry in 2016.Electric Literature of C5H9N3 This article mentions the following:","og_url":"https:\/\/www.pyrazoles-derivatives.com\/?p=12256","og_site_name":"pyrazoles-derivatives","article_published_time":"2023-02-12T20:17:49+00:00","author":"Jessica.F","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jessica.F","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.pyrazoles-derivatives.com\/?p=12256","url":"https:\/\/www.pyrazoles-derivatives.com\/?p=12256","name":"Blake, James F. et al. published their research in Journal of Medicinal Chemistry in 2016 | CAS: 3528-58-3 | pyrazoles-derivatives","isPartOf":{"@id":"https:\/\/www.pyrazoles-derivatives.com\/#website"},"datePublished":"2023-02-12T20:17:49+00:00","author":{"@id":"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1"},"description":"Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1\/2 (ERK1\/2) Inhibitor in Early Clinical Development was written by Blake, James F.;Burkard, Michael;Chan, Jocelyn;Chen, Huifen;Chou, Kang-Jye;Diaz, Dolores;Dudley, Danette A.;Gaudino, John J.;Gould, Stephen E.;Grina, Jonas;Hunsaker, Thomas;Liu, Lichuan;Martinson, Matthew;Moreno, David;Mueller, Lars;Orr, Christine;Pacheco, Patricia;Qin, Ann;Rasor, Kevin;Ren, Li;Robarge, Kirk;Shahidi-Latham, Sheerin;Stults, Jeffrey;Sullivan, Francis;Wang, Weiru;Yin, Jianping;Zhou, Aihe;Belvin, Marcia;Merchant, Mark;Moffat, John;Schwarz, Jacob B.. And the article was included in Journal of Medicinal Chemistry in 2016.Electric Literature of C5H9N3 This article mentions the following:","breadcrumb":{"@id":"https:\/\/www.pyrazoles-derivatives.com\/?p=12256#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pyrazoles-derivatives.com\/?p=12256"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.pyrazoles-derivatives.com\/?p=12256#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/www.pyrazoles-derivatives.com\/"},{"@type":"ListItem","position":2,"name":"Blake, James F. et al. published their research in Journal of Medicinal Chemistry in 2016 | CAS: 3528-58-3"}]},{"@type":"WebSite","@id":"https:\/\/www.pyrazoles-derivatives.com\/#website","url":"https:\/\/www.pyrazoles-derivatives.com\/","name":"pyrazoles-derivatives","description":"Several pyrazole derivatives possess important pharmacological activities and they have been proved useful materials in drug research. Pyrazole derivatives play an important role in antitumor agents.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pyrazoles-derivatives.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1","name":"Jessica.F","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/image\/","url":"https:\/\/cn.cravatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g","contentUrl":"https:\/\/cn.cravatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g","caption":"Jessica.F"}}]}},"_links":{"self":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/posts\/12256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12256"}],"version-history":[{"count":0,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/posts\/12256\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}